Procyrion is dedicated to improving outcomes for patients with cardiac and renal impairment using its catheter-deployed pump technology to address conditions with significant unmet needs. Aortix™ is a percutaneous mechanical circulatory support device that treats cardiorenal syndrome with a rapidly-deployed intra-aortic catheter-based system.
Aortix™ is currently in the research and development phase and is not available for sale in any country.
(Caution: investigational device. Limited by federal law to investigational use.)
Location: United States, Texas, Houston
Employees: 11-50
Total raised: $97.7M
Founded date: 2005
Investors 2
| Date | Name | Website |
| - | BlueBird V... | bluebirdvc... |
| 13.05.2024 | Texas Vent... | texasventu... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 05.02.2024 | Series E | $57.7M | - |
| 01.08.2019 | Series D | $30M | BlueBird V... |
| 09.10.2015 | Series B | $10M | - |
Mentions in press and media 16
| Date | Title | Description |
| 12.04.2024 | Here's what Houston startups have raised in funding so far in 2024 | Five Houston startups have started the new year strong with over $320 million in venture funding — most of which from one mega deal for a geothermal company. According to InnovationMap reporting, Houston's VC activity in the first quarter o... |
| 12.04.2024 | RBPC's big winners, Hello Alice scores funding, and more trending Houston innovation news | Editor's note:Let's roundup the top Houston innovation news from the week. Trending Houston tech and startup articles on InnovationMap included the results from the 2024 Rice Business Plan Competition, recent funding from a Houston startup,... |
| 05.02.2024 | Procyrion Closes $57.7M in Series E Funding | Procyrion, a Houston, TX-based medical device company, raised $57.7M in Series E funding, including the conversion of $10.0M of interim financing. The round was led by Fannin Partners in partnership with new and existing family/multi-family... |
| 05.02.2024 | Procyrion raises $57M to complete development of its percutaneous heart failure pump | Procyrion has assembled $57.7 million in proceeds to continue the pivotal trial of its miniaturized pumps to help maintain blood flow in patients suffering from severe heart failure. The company’s series E round was led by Fannin Partners, ... |
| 31.01.2024 | Houston innovator plays the long game of life science innovation with optimized capital efficiency | Commercializing a life science innovation that has the potential to enhance or even save the lives of millions of patients is a marathon, not a sprint. That's how Atul Varadhachary thinks of it, and he's leading an organization that's activ... |
| 12.07.2019 | Houston medical device company closes $30 million round | A clinical-stage medical device company based in Houston has rounded up $30 million for its Series D funding. Procyrion Inc.'s round was lead by Bluebird Ventures — a new funding partner for the company. Procyrion is developing a blood pump... |
| 09.07.2019 | Procyrion Raises $30M to Support Clinical Trials of its Percutaneous Blood Pump Device | Procyrion, Inc., a Houston-based medical device firm developing the first catheter-deployed, intra-aortic pump initially for use in cardiorenal syndrome patients announced it has raised $30 million in Series D funding led by Bluebird Ventur... |
| 13.02.2018 | Term Sheet — Tuesday, February 13 | BIOTECH BOOM Good morning, Term Sheet readers. Paid Content A.I. is the answer to protecting your enterprise in the cloud From ExtraHop We think poor people should benefit from the same kind of innovation in health and agriculture that has ... |
| 30.10.2017 | Corinnova Nets $6.1M from Wellcome for Heart Failure Medical Device | Share Share on Facebook Share on Twitter LinkedIn Email Reprints Houston—More than 12 million people in the United States and European Union have congestive heart failure, but there are only about 4,500 hearts available each year for transp... |
| 09.10.2015 | Daily funding roundup - October 9, 2015 | Segment bagged $27M; Glamsquad raised $15M; SightCall landed $8.4M On Friday Segment, a company that wants to make accessing data as easy as possible across companies announced that it has raised $27 million in a Series B round led by Thriv... |
Show more